Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - OTHER LONG-TERM ASSETS
Other Long-term Assets NBIX - Neurocrine Biosciences, Inc.
755 M
LAST VALUE
449.55%
2 YEAR CAGR
198.24%
5 YEAR CAGR
65.73%
10 YEAR CAGR